These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9612089)
1. The role of IP prostanoid receptors in inflammatory pain. Bley KR; Hunter JC; Eglen RM; Smith JA Trends Pharmacol Sci; 1998 Apr; 19(4):141-7. PubMed ID: 9612089 [TBL] [Abstract][Full Text] [Related]
2. Characterization of prostanoid receptor-evoked responses in rat sensory neurones. Smith JA; Amagasu SM; Eglen RM; Hunter JC; Bley KR Br J Pharmacol; 1998 Jun; 124(3):513-23. PubMed ID: 9647476 [TBL] [Abstract][Full Text] [Related]
3. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Moriyama T; Higashi T; Togashi K; Iida T; Segi E; Sugimoto Y; Tominaga T; Narumiya S; Tominaga M Mol Pain; 2005 Jan; 1():3. PubMed ID: 15813989 [TBL] [Abstract][Full Text] [Related]
4. Central nociceptive role of prostacyclin (IP) receptor induced by peripheral inflammation. Doi Y; Minami T; Nishizawa M; Mabuchi T; Mori H; Ito S Neuroreport; 2002 Jan; 13(1):93-6. PubMed ID: 11924902 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Meja KK; Barnes PJ; Giembycz MA Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541 [TBL] [Abstract][Full Text] [Related]
6. Major roles of prostanoid receptors IP and EP(3) in endotoxin-induced enhancement of pain perception. Ueno A; Matsumoto H; Naraba H; Ikeda Y; Ushikubi F; Matsuoka T; Narumiya S; Sugimoto Y; Ichikawa A; Oh-ishi S Biochem Pharmacol; 2001 Jul; 62(2):157-60. PubMed ID: 11389873 [TBL] [Abstract][Full Text] [Related]
8. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum. Lawrence RA; Jones RL; Wilson NH Br J Pharmacol; 1992 Feb; 105(2):271-8. PubMed ID: 1559125 [TBL] [Abstract][Full Text] [Related]
10. Stimulation of prostanoid IP and EP(2) receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats. Mori A; Saito M; Sakamoto K; Narita M; Nakahara T; Ishii K Eur J Pharmacol; 2007 Sep; 570(1-3):135-41. PubMed ID: 17628525 [TBL] [Abstract][Full Text] [Related]
11. In vitro pharmacological characterization of the prostanoid receptor population in the non-pregnant porcine myometrium. Cao J; Shayibuzhati M; Tajima T; Kitazawa T; Taneike T Eur J Pharmacol; 2002 May; 442(1-2):115-23. PubMed ID: 12020689 [TBL] [Abstract][Full Text] [Related]
12. Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors. Orie NN; Clapp LH Eur J Pharmacol; 2011 Mar; 654(3):258-65. PubMed ID: 21185823 [TBL] [Abstract][Full Text] [Related]
13. Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. Honda T; Segi-Nishida E; Miyachi Y; Narumiya S J Exp Med; 2006 Feb; 203(2):325-35. PubMed ID: 16446378 [TBL] [Abstract][Full Text] [Related]
14. Focus on prostacyclin and its novel mimetics. Wise H; Jones RL Trends Pharmacol Sci; 1996 Jan; 17(1):17-21. PubMed ID: 8789354 [TBL] [Abstract][Full Text] [Related]
15. Evidence for involvement of prostaglandin I2 as a major nociceptive mediator in acetic acid-induced writhing reaction: a study using IP-receptor disrupted mice. Ohishi S; Ueno A; Matsumoto H; Murata T; Ushikubi F; Narumiya S Adv Exp Med Biol; 1999; 469():265-8. PubMed ID: 10667340 [No Abstract] [Full Text] [Related]
16. Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery. Baxter GS; Clayton JK; Coleman RA; Marshall K; Sangha R; Senior J Br J Pharmacol; 1995 Sep; 116(1):1692-6. PubMed ID: 8564239 [TBL] [Abstract][Full Text] [Related]
17. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Murata T; Ushikubi F; Matsuoka T; Hirata M; Yamasaki A; Sugimoto Y; Ichikawa A; Aze Y; Tanaka T; Yoshida N; Ueno A; Oh-ishi S; Narumiya S Nature; 1997 Aug; 388(6643):678-82. PubMed ID: 9262402 [TBL] [Abstract][Full Text] [Related]
18. Regulation of the human prostanoid TPalpha and TPbeta receptor isoforms mediated through activation of the EP(1) and IP receptors. Walsh MT; Kinsella BT Br J Pharmacol; 2000 Oct; 131(3):601-9. PubMed ID: 11015313 [TBL] [Abstract][Full Text] [Related]
19. Protective Role of mPGES-1 (Microsomal Prostaglandin E Synthase-1)-Derived PGE Hao H; Hu S; Wan Q; Xu C; Chen H; Zhu L; Xu Z; Meng J; Breyer RM; Li N; Liu DP; FitzGerald GA; Wang M Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1115-1124. PubMed ID: 29599139 [TBL] [Abstract][Full Text] [Related]
20. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Minami T; Nakano H; Kobayashi T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Ito S Br J Pharmacol; 2001 Jun; 133(3):438-44. PubMed ID: 11375261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]